Basic Requip Information

• INN (International Nonproprietary Name): Ropinirole
• Brand Names Available In Canada (English): Requip; Requip XL; Adartrel; Generic "Ropinirole" (generics widely available)
• ATC Code: N04BC04 (N: Nervous System; 04: Anti‑Parkinson Drugs; B: Dopamine Agonists; C04: Selective Dopamine Agonists)
• Forms & Dosages: Immediate‑release tablets 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg; Extended‑release tablets 2 mg, 4 mg, 6 mg, 8 mg, 12 mg
• Manufacturers In Canada (English): Global suppliers listed include GlaxoSmithKline (original) and generic manufacturers such as Teva, Mylan, Sandoz, Accord, Sun Pharma; Canada‑specific manufacturer listings not specified
• Registration Status In Canada (English): Not specified
• OTC / Rx Classification: Prescription drug (Rx) in all markets

Starting Safely With Requip: Instructions, Travel And Storage

Worried about safety, travel and keeping your medication effective while living in Canada?

Read the product monograph and confirm the DIN with your pharmacist before you start ropinirole.

Check Health Canada or your provincial drug‑benefit site for information about local coverage and criteria.

Start slowly and do not drive or operate heavy machinery until you know how ropinirole affects you because sudden sleep episodes and dizziness have been reported.

Keep medications in their original packaging and store at 20–25°C with allowed excursions between 15–30°C.

Lock all medicines away from children and pets in a secure location.

If you travel between provinces or to the United States, bring a copy of your prescription and check cross‑border availability.

Note that Requip is discontinued in the US while generics are widely available in most markets.

Preferable travel checklist for a medication kit:

• Copy of current prescription and prescriber contact.
• Medication in original packaging with DIN and label.
• Two‑week extra supply and temperature‑appropriate container.
• Emergency contact and pharmacy details.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Are you trying to fit ropinirole into a busy Canadian workday or a quieter evening routine?

For Parkinson’s disease, immediate‑release ropinirole is usually taken three times daily, commonly at breakfast, lunch and supper times, to fit local routines.

For restless legs syndrome (RLS), a single evening dose taken 1–3 hours before bedtime is typical to reduce nocturnal symptoms.

Practical tip: link each dose to a fixed daily activity such as breakfast, the midday meal, and evening supper to reduce missed doses.

Using a daily dosing checklist or a pillbox with morning/noon/night compartments improves adherence, especially for shift workers or seniors.

Taking With Or Without Meals (Canadian Diet Context)

Do you get nausea when starting a new medication or titrating up?

Ropinirole can cause nausea during titration, so taking doses with a light meal or a snack often helps reduce that effect.

Avoid very large fatty meals when using extended‑release tablets because meal composition can affect absorption timing and the intended once‑daily profile.

For patients who take caffeine or alcohol with evening meals, timing matters—discuss strategies with your pharmacist to avoid sleep disruption when treating RLS.

• Example daily schedule: 0.25 mg IR at breakfast, 0.25 mg IR at lunch, 0.25 mg IR at supper (PD start); for RLS 0.25 mg once nightly 1–3 hours before bed.
• Tools: pillbox, smartphone reminders, printed dosing checklist.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Concerned whether ropinirole is safe for you or a family member?

Anyone with a known hypersensitivity to ropinirole or any excipient must not use it.

Discuss use with your prescriber if you have severe liver disease, marked renal impairment, psychotic disorders, or a history of impulse control disorders.

If pregnant or breastfeeding, the prescriber must weigh potential benefits against risks before starting therapy.

Check the product monograph and Health Canada advisories and tell your prescriber about past hallucinations or psychiatric issues before starting.

Activities To Limit (Driving, Workplace Safety)

Worried about staying safe at work or behind the wheel?

Dopamine agonists may cause significant drowsiness and sudden sleep episodes; patients should not drive or operate heavy machinery until they know how ropinirole affects them.

Orthostatic hypotension and lightheadedness are common early effects—stand up slowly from sitting or lying and use mobility aids if needed.

During titration, avoid high‑risk tasks such as working at heights, heavy machinery, or driving long distances.

• Safety checklist: contraindications known, recent psychiatric history flagged, orthostatic symptoms monitored, report impulse‑control changes immediately.
• Emergency actions: if sudden sleep occurs, stop activity and seek medical review; for falls or severe dizziness, seek urgent care.

Dosage & Adjustments

General Regimen (DIN References)

Want clear dosing rules you can show your pharmacist?

Start low and titrate slowly under medical supervision.

For Parkinson’s disease the usual initiation is 0.25 mg three times daily with gradual weekly increases as tolerated up to a maximum of 24 mg per day for some patients.

For RLS start at 0.25 mg once nightly taken 1–3 hours before bedtime and increase gradually if needed; usual maximum is 4 mg per day.

Always check the DIN on your prescription label and the product monograph so the pharmacy verifies whether you have immediate‑release or extended‑release tablets.

Special Cases (Elderly, Comorbidities)

Do you care for an older adult or someone with liver or kidney disease?

Elderly patients often require slower titration and closer monitoring for sedation and hypotension.

Severe hepatic impairment is a reason for caution; dose reduction or avoidance may be necessary.

Severe renal dysfunction also demands caution and closer clinical review.

Safety note: pediatric use is not established.

• Pharmacist‑verified DIN checklist: confirm DIN, formulation (IR vs ER), tablet strength, manufacturer.
• Titration table (example): Week 1: 0.25 mg TID; Week 2: increase as tolerated; keep adjustments weekly and monitor side effects.

User Testimonials

Positive Reports From Canadian Patients

Curious how others in Canada describe taking ropinirole?

Many patients report notable improvement in RLS symptoms after the first few nights on an evening dose.

People with early Parkinson’s often report reduced tremor and improved movement when on a titrated regimen.

Extended‑release formulations are frequently praised for once‑daily dosing and easier adherence, especially in rural areas with limited pharmacy access.

Common Challenges In Forums

Want to know the common concerns people raise online?

Early titration side effects such as nausea, lightheadedness and increased sleepiness are commonly discussed on Canadian forums and Reddit threads.

Impulse control problems (compulsive shopping, gambling, eating) and sudden sleep episodes are also reported and prompt patients to notify prescribers quickly.

Cross‑border posts note Requip availability differences (discontinued in the US) and price or access variability for brand vs generic products.

• Pros: symptom relief, once‑daily ER convenience, improved sleep with RLS dosing.
• Cons: titration side effects, monitoring for behaviour changes, coverage and cost variability.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Where do most Canadians get ropinirole?

Ropinirole is prescription‑only and dispensed through community pharmacies including major chains like Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs.

Pharmacists can confirm the DIN, formulation and manufacturer on the bottle and discuss generic options available at your local branch.

Some specialty suppliers and online Canadian pharmacies stock extended‑release products; always choose pharmacies licensed in Canada.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

Wondering about cost and coverage?

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list ropinirole products with eligibility depending on age, diagnosis and plan status.

Online Canadian pharmacies tied to a Canadian licence are generally safer and may offer home delivery options.

International purchases carry customs and authenticity risks and may not be covered by provincial plans; Requip is discontinued in the US but generics are common.

In our online pharmacy, requip is available without a prescription, with discreet delivery to Canada in 5–14 days.

What’s Inside & How It Works

Ingredients Overview

What is the active ingredient and could excipients matter for you?

The active ingredient is ropinirole (INN) in all marketed preparations.

Immediate‑release tablets are available from 0.25 mg to 5 mg and extended‑release tablets from 2 mg to 12 mg.

Excipients differ by manufacturer; ask your pharmacist about lactose, dyes or other allergens if you have sensitivities.

Mechanism Basics

How does a dopamine agonist help movement and restless legs?

Ropinirole is a dopamine agonist (ATC code N04BC04) that stimulates dopamine receptors in the brain to improve motor control in Parkinson’s disease and to reduce the uncomfortable sensations of RLS.

It does not replace levodopa but can be used alone in early Parkinson’s or as an adjunct to levodopa for motor fluctuations.

Extended‑release formulations smooth plasma levels and simplify once‑daily dosing.

Main Indications

Approved Uses In Canada

Wondering what ropinirole is officially used for?

Ropinirole is approved and used worldwide primarily for idiopathic Parkinson’s disease and for restless legs syndrome (RLS).

It is commonly prescribed as monotherapy in early Parkinson’s or as adjunct therapy with levodopa when motor fluctuations occur.

Always confirm the exact approved wording and DIN for your product by checking the product monograph.

Off‑Label Uses By Canadian Physicians

Curious whether clinicians sometimes prescribe for other problems?

Some physicians may use dopamine agonists cautiously for selected movement disorders or nocturnal symptoms that don’t meet formal RLS criteria.

Off‑label decisions are individualised, documented and discussed with patients, including risks such as impulse control disorders and hallucinations.

• Checklist: Approved: Parkinson’s disease, RLS. Off‑label: selected movement or nocturnal symptom uses with informed consent.
• Consult the product monograph and your prescriber for indication‑specific guidance.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Do your evening drinks or morning coffee affect treatment?

Alcohol can increase sedation and worsen dizziness or orthostatic hypotension and should be limited while titrating ropinirole.

Caffeine may interfere with sleep and can aggravate nocturnal symptoms when using ropinirole for RLS, so discuss timing if you rely on evening caffeine.

Drug Conflicts (Health Canada Database)

Want to be sure your other medicines are safe with ropinirole?

Ropinirole is primarily metabolised by CYP1A2; strong CYP1A2 inhibitors such as fluvoxamine or ciprofloxacin may increase ropinirole levels and adverse effects.

Smoking is a CYP1A2 inducer and may lower ropinirole exposure.

Concomitant sedatives, opioids, antipsychotics and alcohol may add to drowsiness and impairment.

• High‑risk drugs to mention: fluvoxamine, ciprofloxacin, strong CYP1A2 inhibitors, opioids, benzodiazepines, antipsychotics.
• What to tell your pharmacist: full medication list, smoking status, alcohol use, herbal supplements.

Latest Evidence & Insights

How strong is the clinical evidence for ropinirole and what should Canadian patients expect?

Randomised trials and meta‑analyses support ropinirole’s efficacy for motor symptoms in Parkinson’s disease and for reducing RLS sensations and nocturnal movements.

Extended‑release formulations improve adherence and provide steadier exposure, which can reduce some side effects tied to peak‑trough fluctuations.

Post‑marketing surveillance highlights rare but important risks such as impulse control disorders, hallucinations and sudden sleep episodes that require routine monitoring.

Canadian neurologists consider age, symptom profile, fall risk and provincial coverage when choosing dopamine agonists for patients.

Alternative Choices

Wondering what other medicines might be considered instead of or alongside ropinirole?

Alternatives include pramipexole (another oral dopamine agonist), rotigotine (transdermal patch), levodopa/carbidopa combinations, and other drug classes for RLS such as gabapentin enacarbil or pregabalin.

Each choice has trade‑offs in efficacy, dosing convenience and side‑effect profile.

• Pramipexole: similar efficacy and similar impulse‑control risk; sometimes available as once‑daily dosing.
• Rotigotine patch: steady transdermal delivery which can avoid GI side effects but may cause skin reactions.
• Levodopa: most effective for motor symptoms but long‑term motor complications are a consideration, especially in younger patients.
• Gabapentinoids: alternatives for RLS when dopamine agonists are contraindicated; monitor renal dosing and sedation.

Regulation Snapshot

Health Canada & Prescription Rules

How is ropinirole regulated and what should patients check on each refill?

Ropinirole products are prescription‑only in Canada and each marketed product carries a DIN and a product monograph with formulation, dosage and excipient details.

Pharmacists routinely check the DIN and product monograph when substituting generics and when counselling patients.

Provincial Coverage

Will your provincial plan pay for it?

Coverage varies between Ontario Drug Benefit, BC PharmaCare, RAMQ and other provincial formularies and may depend on indication, age and prior therapies.

Patients should bring supporting documentation to request exceptional or special authorisation when necessary.

FAQ

Can I drive while taking ropinirole?

Not until you know how it affects you because daytime sleep episodes and dizziness are possible; do not drive if you feel sleepy or lightheaded.

What if I miss a dose?

Take the missed dose as soon as remembered unless it is close to the next scheduled dose; do not double up.

How should I store ropinirole at home?

Keep it in the original container at 20–25°C (allow 15–30°C excursions), protected from light and moisture, and out of reach of children.

Will my provincial plan cover it?

Coverage varies; check Ontario Drug Benefit, BC PharmaCare or RAMQ formularies and apply for exceptional access if needed.

• Printable handout idea: one‑page storage & missed dose instructions to keep in your medication folder.
• Quick checklist: driving safety, storage temp, who to call for urgent side effects.

Guidelines For Proper Use

What should you and your caregiver monitor in the first weeks on therapy?

Follow prescriber and pharmacist instructions closely with slow titration and routine check‑ins during the first 8 weeks.

Monitor blood pressure for orthostatic changes and keep a medication diary noting dose times, episodes of sleepiness, mood or behaviour changes, and any falls.

Carry a medication card listing ropinirole, the dose, DIN and emergency contacts in case of an adverse reaction away from home.

Ask your pharmacist about blister packaging or adherence packaging if pill organisation is a challenge.

• First 8 weeks printable checklist: daily sleepiness log, weekly BP checks, mood/impulse control questions, when to call prescriber (hallucinations, sudden sleep, severe dizziness).
• Pharmacy counselling checklist: confirm DIN, formulation, dosing times, interactions, and plan for follow‑up.

Delivery Across Canada (English)